RG
SRNE

Rathbones Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Rathbones Group’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-40,784
Closed -$395K – 439
2021
Q2 		$395K Sell
40,784
-1,700
-4% -$13.5K ﹤0.01% 332
2021
Q1 		$351K Hold
42,484
– – ﹤0.01% 326
2020
Q4 		$290K Hold
42,484
– – ﹤0.01% 334
2020
Q3 		$474K Sell
42,484
-3,000
-7% -$27.5K 0.01% 265
2020
Q2 		$286K Sell
45,484
-1,300
-3% -$4.98K 0.01% 296
2020
Q1 		$86K Sell
46,784
-15,000
-24% -$43.2K ﹤0.01% 303
2019
Q4 		$209K Hold
61,784
– – 0.01% 305
2019
Q3 		$132K Buy
+61,784
New +$144K ﹤0.01% 309

Other funds holding SRNE

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return